Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin in Chronic Rhinosinusitis With Nasal Polyps
NCT07780292Phase 4Not yet recruiting
- Sponsor
- Assiut University
- Start
- Oct 2026
- Primary completion
- Oct 2027
01
Overview
Phase 4, randomised trial of azithromycin in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Assiut University. Primary endpoint: Recurrence rate of rhinosinusitis at 12 weeks. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
azithromycin
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT07780292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07780292.